Pharmaceutical Business review

Mylan Pharma rolls out generic benign prostatic hyperplasia drug

Mylan‘s Alfuzosin Hydrochloride Extended-release Tablets, 10mg are generic equivalent to Uroxatral, indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.

Uroxatral belongs to a group of drugs called alpha-adrenergic blockers.

Uroxatral relaxes the muscles in the prostate and bladder neck, making it easier to urinate.